#1 Clinical Trials Search in Europe

Ebastine

Ebastine, a histamine H1 receptor antagonist, is being studied in several clinical trials for its potential benefits in treating various conditions. This article examines the use of Ebastine in clinical trials for irritable bowel syndrome (IBS), metastatic castration-resistant prostate cancer, and urticaria. We’ll explore the drug’s effectiveness, dosage, and potential side effects across different medical applications.

Table of Contents

What is Ebastine?

Ebastine is a medication that belongs to a class of drugs called antihistamines. Specifically, it is a histamine 1 receptor antagonist, which means it blocks the effects of histamine in the body[1]. Histamine is a substance that your body produces during allergic reactions and in response to certain stimuli, leading to symptoms like itching, swelling, and inflammation.

Conditions Treated with Ebastine

Ebastine is being studied and used to treat several conditions:

  • Irritable Bowel Syndrome (IBS): Ebastine is being investigated as a potential treatment for IBS, particularly for patients with non-constipated IBS. It may help reduce abdominal pain and improve overall symptoms[1][3].
  • Urticaria: Also known as hives, urticaria is a skin condition characterized by itchy, red welts. Ebastine is being studied as a treatment option for this condition[5].
  • Metastatic Castration-resistant Prostate Cancer: Interestingly, ebastine is also being investigated in combination with another drug called docetaxel for the treatment of advanced prostate cancer[2].

How Ebastine Works

Ebastine works by blocking histamine receptors in the body. In the case of IBS, researchers believe that blocking these receptors may help reduce abdominal pain and improve overall symptoms. For urticaria, blocking histamine receptors can help reduce itching and swelling associated with hives[1][5].

In the context of prostate cancer treatment, the exact mechanism is still being studied. Researchers are investigating whether ebastine can enhance the effects of chemotherapy drugs like docetaxel[2].

Current Clinical Trials

Several clinical trials are currently underway to evaluate the effectiveness of ebastine for various conditions:

  1. IBS Treatment: A multicenter randomized controlled trial is comparing ebastine to mebeverine (another commonly used IBS medication) in patients with non-constipated IBS[1].
  2. Prostate Cancer Treatment: An open-label phase I/II study is evaluating the addition of ebastine to docetaxel in the treatment of metastatic castration-resistant prostate cancer[2].
  3. IBS and Visceral Hypersensitivity: A study is investigating the effect of ebastine on clinical symptoms and visceral hypersensitivity in IBS patients[4].

Dosage and Administration

The dosage and administration of ebastine can vary depending on the condition being treated and the specific clinical trial. Here are some examples from the ongoing studies:

  • For IBS treatment: 20mg once daily for 12 weeks[3][4].
  • For prostate cancer treatment: Administered once daily in combination with docetaxel every three weeks[2].

It’s important to note that these dosages are specific to clinical trials and may not reflect approved dosages for general use. Always follow your doctor’s instructions regarding medication use.

Potential Side Effects

While ebastine is generally considered to have a good safety profile, like all medications, it can have side effects. In clinical trials, researchers are monitoring for potential side effects, which may include:

  • Drowsiness or sleepiness
  • Interference with daily activities due to sleepiness
  • Non-restful sleep[5]

It’s important to note that the full range of potential side effects may not be known until more extensive studies are completed. Always report any unusual symptoms to your healthcare provider.

Other Names for Ebastine

Ebastine may be known by different brand names in various countries. Some of the names mentioned in the clinical trials include:

It’s important to note that the availability and brand names of ebastine may vary depending on your location and the specific formulation being used.

Condition Dosage Duration Primary Outcome Measures
Irritable Bowel Syndrome (IBS) 20mg once daily 12 weeks Global symptom relief, abdominal pain reduction
Metastatic Castration-resistant Prostate Cancer Once daily (with Docetaxel) Up to 10 cycles (each cycle 21 days) Changes in urinary and blood lipid profiles
Urticaria Varies (standard dose and quadruple dose tested) 2 months Improvement in Urticaria Activity Score and Life Quality Index

FAQ

  • What is Ebastine and how does it work? Ebastine is an antihistamine that works by blocking histamine H1 receptors. It is being studied for its potential to alleviate symptoms in conditions like irritable bowel syndrome, urticaria, and as a complementary treatment in certain cancers.
  • In which conditions is Ebastine being studied? Ebastine is being investigated in clinical trials for irritable bowel syndrome (IBS), metastatic castration-resistant prostate cancer, and urticaria (hives).
  • How is Ebastine administered in these trials? In most trials, Ebastine is administered orally once daily. For example, in IBS trials, patients typically receive 20mg of Ebastine once daily for 12 weeks.
  • What are the primary outcomes being measured in these trials? The primary outcomes vary depending on the condition being studied. For IBS, researchers are looking at symptom relief and changes in abdominal pain. In prostate cancer trials, they're examining changes in urinary and blood lipids. For urticaria, the focus is on symptom improvement and quality of life.
  • Are there any known side effects of Ebastine? While specific side effects aren't detailed in these trial descriptions, antihistamines like Ebastine may cause drowsiness in some people. The trials include safety assessments to monitor for any adverse effects.

Ongoing Clinical Trials on Ebastine

  • Study of Ebastine and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients with Advanced Disease

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark

  • Study Comparing Ebastine and Mebeverine for Treating Irritable Bowel Syndrome in Adults

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study comparing bilastine, ebastine, and desloratadine in preventing histamine-induced skin reactions in healthy volunteers

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    1 1 1
    Investigated drugs:
    Germany

Glossary

  • Histamine H1 receptor antagonist: A type of medication that blocks the action of histamine, a substance in the body that can cause allergy symptoms and inflammation.
  • Irritable Bowel Syndrome (IBS): A common digestive disorder that affects the large intestine, causing symptoms such as abdominal pain, bloating, and changes in bowel habits.
  • Metastatic Castration-resistant Prostate Cancer: An advanced form of prostate cancer that continues to grow even when the amount of testosterone in the body is reduced to very low levels.
  • Urticaria: Also known as hives, it's a skin reaction that causes itchy, raised welts on the surface of the skin.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs.
  • Double-blind: A type of clinical trial where neither the participants nor the researchers know who is receiving the experimental treatment and who is receiving a placebo or standard treatment.
  • Randomized controlled trial: A study design that randomly assigns participants into an experimental group or a control group to compare the outcomes.
  • Barostat test: A medical test used to measure sensitivity and muscle tone in the digestive tract.
  • Visceral hypersensitivity: Increased sensitivity of the internal organs to stimuli, often associated with chronic pain conditions like IBS.
  • PSA (Prostate-Specific Antigen): A protein produced by the prostate gland; elevated levels may indicate prostate cancer or other prostate conditions.

References

  1. https://clinicaltrials.gov/study/NCT05815602
  2. https://clinicaltrials.gov/study/NCT06480110
  3. https://clinicaltrials.gov/study/NCT01908465
  4. https://clinicaltrials.gov/study/NCT01144832
  5. https://clinicaltrials.gov/study/NCT01940393